SoftBank, through its Vision Fund II, led a USD100m Series C for Biofourmis, a US-based AI and digital therapeutics startup originally founded in Singapore, with participation from returning investors Openspace Ventures, MassMutual Ventures, Sequoia Capital, and EDBI. Read more